Menu Search
Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Learn moreSubscribe now
Equities

JBM (Healthcare) Ltd

2161:HKG.HZ

JBM (Healthcare) Ltd

Actions
  • Price (HKD)1.17
  • Today's Change0.21 / 21.88%
  • Shares traded12.35m
  • 1 Year change+7.34%
  • Beta--
Data delayed at least 15 minutes, as of Nov 01 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

JBM Healthcare Ltd is an investment holding company mainly engages in the marketing and distribution of proprietary Chinese medicines. The Company operates its business through three segments. The Proprietary Chinese Medicines segment mainly distributes over the counter (OTC) proprietary Chinese medicines and concentrated Chinese medicine granule (CCMG) products. The Consumer Healthcare Products segment primarily distributes proprietary medicines in the form of OTC. The Health and Wellness Products segment sales and distributes health and wellness products. The Company operates business in domestic and overseas markets such as Southeast Asia, Europe, and North America.

  • Revenue in HKD (TTM)648.42m
  • Net income in HKD130.46m
  • Incorporated2020
  • Employees279.00
  • Location
    JBM (Healthcare) LtdUnit 2303-07, 23/F, Tower 1, Millennium388 Kwun Tong Road, Kwun Tong, KowloonKOWLOON Hong KongHKG
  • Phone+852 22672178
  • Websitehttps://www.jbmhealthcare.com.hk/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.